Last updated on February 2019

A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: childhood ALL
  • Age: Between 1 - 18 Years
  • Gender: Male or Female

Inclusion Criteria:

  • ALL L1 or L2
  • B-lineage or T- lineage ALL

Exclusion Criteria:

  • L3 (Burkitt's leukemia)
  • Mixed Phenotype Acute Leukemia (WHO criteria).
  • Infant ALL (age 365 days)
  • Philadelphia (Ph)+/Breakpoint Cluster region (BCR)-Abelson (ABL) ALL

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.